PL1664289T3 - Fosfodiesterazy cyklicznych nukleotydów pochodzące z Leishmania i ich zastosowanie - Google Patents

Fosfodiesterazy cyklicznych nukleotydów pochodzące z Leishmania i ich zastosowanie

Info

Publication number
PL1664289T3
PL1664289T3 PL04787575T PL04787575T PL1664289T3 PL 1664289 T3 PL1664289 T3 PL 1664289T3 PL 04787575 T PL04787575 T PL 04787575T PL 04787575 T PL04787575 T PL 04787575T PL 1664289 T3 PL1664289 T3 PL 1664289T3
Authority
PL
Poland
Prior art keywords
leishmania
cyclic nucleotide
specific phosphodiesterases
phosphodiesterases
specific
Prior art date
Application number
PL04787575T
Other languages
English (en)
Inventor
Andrea Johner
Thomas Seebeck
Yasmin Shakur
Original Assignee
Univ Bern
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bern, Otsuka Pharma Co Ltd filed Critical Univ Bern
Publication of PL1664289T3 publication Critical patent/PL1664289T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
PL04787575T 2003-09-05 2004-09-03 Fosfodiesterazy cyklicznych nukleotydów pochodzące z Leishmania i ich zastosowanie PL1664289T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US50024403P 2003-09-05 2003-09-05
US50407003P 2003-09-19 2003-09-19
US58258404P 2004-06-25 2004-06-25
PCT/IB2004/003990 WO2005023856A2 (en) 2003-09-05 2004-09-03 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof
EP04787575A EP1664289B1 (en) 2003-09-05 2004-09-03 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof

Publications (1)

Publication Number Publication Date
PL1664289T3 true PL1664289T3 (pl) 2011-05-31

Family

ID=34279822

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04787575T PL1664289T3 (pl) 2003-09-05 2004-09-03 Fosfodiesterazy cyklicznych nukleotydów pochodzące z Leishmania i ich zastosowanie

Country Status (12)

Country Link
US (3) US7785849B2 (pl)
EP (1) EP1664289B1 (pl)
AR (1) AR045599A1 (pl)
AT (1) ATE492632T1 (pl)
AU (1) AU2004270494B2 (pl)
CA (1) CA2538012A1 (pl)
DE (1) DE602004030695D1 (pl)
DK (1) DK1664289T3 (pl)
PL (1) PL1664289T3 (pl)
PT (1) PT1664289E (pl)
TW (1) TW200518770A (pl)
WO (1) WO2005023856A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007124115A2 (en) * 2006-04-20 2007-11-01 Trustees Of Boston College Compositions and methods for identifying inhibitors and activators of cyclic amp phosphodiesterases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022661A2 (en) * 2000-09-12 2002-03-21 Beavo Joseph A NOVEL PDEs AND USES THEREOF

Also Published As

Publication number Publication date
PT1664289E (pt) 2011-03-17
CA2538012A1 (en) 2005-03-17
WO2005023856A2 (en) 2005-03-17
US20110045491A1 (en) 2011-02-24
DE602004030695D1 (de) 2011-02-03
US20130143250A1 (en) 2013-06-06
EP1664289B1 (en) 2010-12-22
AU2004270494B2 (en) 2010-10-14
AR045599A1 (es) 2005-11-02
ATE492632T1 (de) 2011-01-15
US20070292847A1 (en) 2007-12-20
US7785849B2 (en) 2010-08-31
WO2005023856A3 (en) 2005-06-02
TW200518770A (en) 2005-06-16
DK1664289T3 (da) 2011-02-14
AU2004270494A1 (en) 2005-03-17
EP1664289A2 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
EP1643907A4 (en) DEVICES AND METHOD FOR MEASURING LIGHT
SG120978A1 (en) Metal-over-metal devices and the method for manufacturing same
HK1088837A1 (en) Clk-peptide and slk-peptide
IL172195A0 (en) Thiotungstate analogues and uses thereof
GB0207438D0 (en) Formulation
PL373887A1 (pl) Nowe fosfolipazy i ich zastosowania
GB0205504D0 (en) Formulation
AU2003296369A8 (en) Imminoamines and preparation thereof
GB2411378B (en) Droplet-deposition related methods and appparatus
GB0317342D0 (en) Connector structure
GB0218898D0 (en) Authenticated objects
PL1664289T3 (pl) Fosfodiesterazy cyklicznych nukleotydów pochodzące z Leishmania i ich zastosowanie
SI1664289T1 (sl) Fosfodiesteraze, specifične za ciklične nukleotide iz leishmanie in uporabe le-teh
EP1618931A4 (en) GAME DEVICE AND GAME PROCESSING METHOD USED THEREOF
GB0305890D0 (en) Active alignment technique
EP1538887A4 (en) KULTI FOUR DEVICE
GB2407205B (en) Field emitters and devices
TW566272U (en) Socket structure
GB0321049D0 (en) Active air
TW576570U (en) Multi-directional tri-polar socket
GB2392840B (en) Aromatherapy devices
GB0209941D0 (en) Air-freshener
AU149271S (en) An urn
AU149061S (en) An urn
GB0221970D0 (en) Lockable plug